Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan.

Yamaba Y, Ito Y, Suzuki K, Kikuchi T, Ogawa K, Fujiuchi S, Hasegawa N, Kurashima A, Higuchi T, Uchiya KI, Watanabe A, Niimi A.

J Infect Chemother. 2019 Jun 22. pii: S1341-321X(19)30163-1. doi: 10.1016/j.jiac.2019.05.028. [Epub ahead of print]

PMID:
31239192
2.

Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.

Furuuchi K, Morimoto K, Yoshiyama T, Tanaka Y, Fujiwara K, Okumura M, Izumi K, Shiraishi Y, Mitarai S, Ogata H, Kurashima A, Yoshimori K, Ohta K, Goto H, Sasaki Y.

Respir Med. 2019 Jun;152:74-80. doi: 10.1016/j.rmed.2019.05.001. Epub 2019 May 8.

PMID:
31128614
3.

Mycobacterium avium Complex Pleuritis with Elevated Anti-glycopeptidolipid-core IgA Antibody Levels in Pleural Effusion.

Furuuchi K, Morimoto K, Fujiwara K, Tanaka Y, Takemura T, Kurashima A, Yoshimori K, Ohta K, Sasaki Y.

Intern Med. 2019 May 22. doi: 10.2169/internalmedicine.2751-19. [Epub ahead of print]

4.

Retrospective evaluation of natural course in mild cases of Mycobacterium avium complex pulmonary disease.

Kimizuka Y, Hoshino Y, Nishimura T, Asami T, Sakakibara Y, Morimoto K, Maeda S, Nakata N, Abe T, Uno S, Namkoong H, Fujiwara H, Funatsu Y, Yagi K, Fujie T, Ishii M, Inase N, Iwata S, Kurashima A, Betsuyaku T, Hasegawa N; Non-Tuberculous Mycobacteriosis-Japan Research Consortium (NTM-JRC).

PLoS One. 2019 Apr 25;14(4):e0216034. doi: 10.1371/journal.pone.0216034. eCollection 2019.

5.

Clinico-microbiological analysis of 121 patients with pulmonary Mycobacteroides abscessus complex disease in Japan - An NTM-JRC study with RIT.

Morimoto K, Nakagawa T, Asami T, Morino E, Fujiwara H, Hase I, Tsujimoto Y, Izumi K, Hayashi Y, Matsuda S, Murase Y, Yano R, Takasaki J, Betsuyaku T, Aono A, Goto H, Nishimura T, Sasaki Y, Hoshino Y, Kurashima A, Ato M, Ogawa K, Hasegawa N, Mitarai S.

Respir Med. 2018 Dec;145:14-20. doi: 10.1016/j.rmed.2018.10.012. Epub 2018 Oct 17.

PMID:
30509703
6.

Efficacy and safety of intermittent maintenance therapy after successful treatment of Mycobacterium avium complex lung disease.

Asakura T, Nakagawa T, Suzuki S, Namkoong H, Morimoto K, Ishii M, Kurashima A, Betsuyaku T, Ogawa K, Hasegawa N; Nontuberculous Mycobacteriosis Japan Research Consortium (NTM-JRC).

J Infect Chemother. 2019 Mar;25(3):218-221. doi: 10.1016/j.jiac.2018.07.021. Epub 2018 Aug 29.

PMID:
30172726
7.

Prevention of aerosol isolation of nontuberculous mycobacterium from the patient's bathroom.

Morimoto K, Aono A, Murase Y, Sekizuka T, Kurashima A, Takaki A, Sasaki Y, Igarashi Y, Chikamatsu K, Goto H, Yamada H, Kuroda M, Mitarai S.

ERJ Open Res. 2018 Jul 3;4(3). pii: 00150-2017. doi: 10.1183/23120541.00150-2017. eCollection 2018 Jul.

8.

Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare lung disease from post-marketing surveillance.

Suzuki K, Kurashima A, Tatsuno K, Kadota JI.

Respir Investig. 2018 Jan;56(1):87-93. doi: 10.1016/j.resinv.2017.11.001. Epub 2017 Dec 6.

PMID:
29325687
9.

Mycobacterium triplex pulmonary disease with acquired macrolide resistance in immunocompetent patients.

Matsuda S, Suzuki S, Morimoto K, Aono A, Nishio K, Asakura T, Sasaki Y, Namkoong H, Nishimura T, Ogata H, Hasegawa N, Kurashima A, Ishii M, Tatsumi K, Mitarai S, Goto H.

Clin Microbiol Infect. 2018 Jun;24(6):671-672. doi: 10.1016/j.cmi.2017.12.018. Epub 2018 Jan 5. No abstract available.

10.

Clinical characteristics of pulmonary Mycobacterium lentiflavum disease in adult patients.

Yagi K, Morimoto K, Ishii M, Namkoong H, Okamori S, Asakura T, Suzuki S, Asami T, Uwamino Y, Funatsu Y, Fujiwara H, Kamata H, Nishimura T, Betsuyaku T, Kurashima A, Hasegawa N.

Int J Infect Dis. 2018 Feb;67:65-69. doi: 10.1016/j.ijid.2017.12.001. Epub 2017 Dec 7.

11.

Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.

Aoki A, Sakagami T, Yoshizawa K, Shima K, Toyama M, Tanabe Y, Moro H, Aoki N, Watanabe S, Koya T, Hasegawa T, Morimoto K, Kurashima A, Hoshino Y, Trapnell BC, Kikuchi T.

Clin Infect Dis. 2018 Apr 3;66(8):1239-1245. doi: 10.1093/cid/cix996.

PMID:
29126235
12.

Preventive Effect of Rifampicin on Alzheimer Disease Needs at Least 450 mg Daily for 1 Year: An FDG-PET Follow-Up Study.

Iizuka T, Morimoto K, Sasaki Y, Kameyama M, Kurashima A, Hayasaka K, Ogata H, Goto H.

Dement Geriatr Cogn Dis Extra. 2017 Jun 19;7(2):204-214. doi: 10.1159/000477343. eCollection 2017 May-Aug.

13.

The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study.

Kadota JI, Kurashima A, Suzuki K.

J Infect Chemother. 2017 May;23(5):293-300. doi: 10.1016/j.jiac.2017.01.007. Epub 2017 Feb 27.

PMID:
28254517
14.

[THE FREQUENCIES AND MANAGEMENT OF ADVERSE REACTIONS IN MULTI-DRUG RESISTANT TUBERCULOSIS TREATMENT].

Sasaki Y, Yoshiyama T, Okumura M, Morimoto K, Miyamoto M, Irina, Yoshimori K, Kurashima A, Ogata H, Gotoh H.

Kekkaku. 2017 Jan;92(1):11-19. Japanese.

PMID:
30646468
15.

A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.

Morimoto K, Hasegawa N, Izumi K, Namkoong H, Uchimura K, Yoshiyama T, Hoshino Y, Kurashima A, Sokunaga J, Shibuya S, Shimojima M, Ato M, Mitarai S.

Ann Am Thorac Soc. 2017 Jan;14(1):49-56. doi: 10.1513/AnnalsATS.201607-573OC.

PMID:
27788025
16.

Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases.

Morimoto K, Namkoong H, Hasegawa N, Nakagawa T, Morino E, Shiraishi Y, Ogawa K, Izumi K, Takasaki J, Yoshiyama T, Hoshino Y, Matsuda S, Hayashi Y, Sasaki Y, Ishii M, Kurashima A, Nishimura T, Betsuyaku T, Goto H; Nontuberculous Mycobacteriosis Japan Research Consortium.

Ann Am Thorac Soc. 2016 Nov;13(11):1904-1911.

PMID:
27513168
17.

Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series.

Namkoong H, Morimoto K, Nishimura T, Tanaka H, Sugiura H, Yamada Y, Kurosaki A, Asakura T, Suzuki S, Fujiwara H, Yagi K, Ishii M, Tasaka S, Betsuyaku T, Hoshino Y, Kurashima A, Hasegawa N.

BMC Infect Dis. 2016 Aug 9;16:396. doi: 10.1186/s12879-016-1689-6.

18.

Pneumothorax associated with nontuberculous mycobacteria: A retrospective study of 69 patients.

Ueyama M, Asakura T, Morimoto K, Namkoong H, Matsuda S, Osawa T, Ishii M, Hasegawa N, Kurashima A, Goto H.

Medicine (Baltimore). 2016 Jul;95(29):e4246. doi: 10.1097/MD.0000000000004246. Erratum in: Medicine (Baltimore). 2016 Oct 07;95(40):e3646.

19.

DNA barcoding and morphological analyses revealed validity of Diadema clarki Ikeda, 1939 (Echinodermata, Echinoidea, Diadematidae).

Chow S, Konishi K, Mekuchi M, Tamaki Y, Nohara K, Takagi M, Niwa K, Teramoto W, Manabe H, Kurogi H, Suzuki S, Ando D, Tadao Jinbo, Kiyomoto M, Hirose M, Shimomura M, Kurashima A, Ishikawa T, Kiyomoto S.

Zookeys. 2016 Apr 27;(585):1-16. doi: 10.3897/zookeys.585.8161. eCollection 2016.

20.

Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan.

Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, Mitarai S.

Emerg Infect Dis. 2016 Jun;22(6):1116-7. doi: 10.3201/eid2206.151086. No abstract available.

21.

Evaluation of Humoral Immunity to Mycobacterium tuberculosis-Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development.

Niki M, Suzukawa M, Akashi S, Nagai H, Ohta K, Inoue M, Niki M, Kaneko Y, Morimoto K, Kurashima A, Kitada S, Matsumoto S, Suzuki K, Hoshino Y.

J Immunol Res. 2015;2015:527395. doi: 10.1155/2015/527395. Epub 2015 Oct 19.

22.

[CLINICO-MICROBIOLOGICAL CHARACTERISTICS OF MYCOBACTERIUM KANSASII PULMONARY DISEASE AT A SPECIALIZED MYCOBACTERIOSIS HOSPITAL IN TOKYO, JAPAN].

Morimoto K, Maeda S, Yoshiyama T, Matsuda S, Uchimura K, Sasaki Y, Kurashima A, Ogata H, Kudoh S, Gotoh H.

Kekkaku. 2015 Apr;90(4):453-6. Japanese.

PMID:
26489147
23.

Three new species of Pseudodactylogyrus (Monogenea: Pseudodactylogyridae) from Australian eels.

Ogawa K, Iwashita M, Hayward CJ, Kurashima A.

Folia Parasitol (Praha). 2015 Aug 28;62. pii: 2015.046. doi: 10.14411/fp.2015.046.

24.

Clinical and microbiological features of definite Mycobacterium gordonae pulmonary disease: the establishment of diagnostic criteria for low-virulence mycobacteria.

Morimoto K, Kazumi Y, Shiraishi Y, Yoshiyama T, Murase Y, Ikushima S, Kurashima A, Kudoh S, Goto H, Maeda S.

Trans R Soc Trop Med Hyg. 2015 Sep;109(9):589-93. doi: 10.1093/trstmh/trv058. Epub 2015 Jul 25.

PMID:
26209978
25.

[Experience of rapid drug desensitization therapy in the treatment of mycobacterial disease].

Sasaki Y, Kurashima A, Morimoto K, Okumura M, Watanabe M, Yoshiyama T, Ogata H, Gotoh H, Kudoh S, Suzuki H.

Kekkaku. 2014 Nov;89(11):797-802. Japanese.

PMID:
25730947
26.

Investigation of the population structure of Mycobacterium abscessus complex strains using 17-locus variable number tandem repeat typing and the further distinction of Mycobacterium massiliense hsp65 genotypes.

Yoshida S, Arikawa K, Tsuyuguchi K, Kurashima A, Harada T, Nagai H, Suzuki K, Iwamoto T, Hayashi S.

J Med Microbiol. 2015 Mar;64(Pt 3):254-61. doi: 10.1099/jmm.0.000016. Epub 2015 Jan 16.

PMID:
25596119
27.

The process of palliative sedation as viewed by physicians and nurses working in palliative care in Brazil.

Spineli VM, Kurashima AY, De Gutiérrez MG.

Palliat Support Care. 2015 Oct;13(5):1293-9. doi: 10.1017/S1478951514001278. Epub 2014 Oct 31.

PMID:
25359102
28.

Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis.

Komiya K, Kurashima A, Ihi T, Nagai H, Matsumoto N, Mizunoe S, Ishii H, Takahashi O, Ohta K, Kudoh S, Kadota J.

Int J Antimicrob Agents. 2014 Aug;44(2):131-5. doi: 10.1016/j.ijantimicag.2014.03.017. Epub 2014 Jun 2.

PMID:
24948577
29.

A new combination and a new species of onchobothriid tapeworm (Cestoda: Tetraphyllidea: Onchobothriidae) from triakid sharks.

Kurashima A, Shimizu T, Mano N, Ogawa K, Fujita T.

Syst Parasitol. 2014 May;88(1):75-83. doi: 10.1007/s11230-014-9486-3. Epub 2014 Apr 8.

PMID:
24711114
30.

Nutritional indicators are correlated with the radiological severity score in patients with Mycobacterium avium complex pulmonary disease: a cross-sectional study.

Morimoto K, Yoshiyama T, Kurashima A, Sasaki Y, Hoshino Y, Yoshimori K, Ogata H, Gemma A, Kudoh S, Shiraishi Y.

Intern Med. 2014;53(5):397-401.

31.

A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan.

Morimoto K, Iwai K, Uchimura K, Okumura M, Yoshiyama T, Yoshimori K, Ogata H, Kurashima A, Gemma A, Kudoh S.

Ann Am Thorac Soc. 2014 Jan;11(1):1-8. doi: 10.1513/AnnalsATS.201303-067OC.

PMID:
24102151
32.

[Clinical experience using rifabutin for treating infection with Mycobacterium tuberculosis in elderly Japanese patients].

Morimoto K, Yoshiyama T, Kuse M, Okumura M, Sasaki Y, Yoshimori K, Ogata H, Kurashima A, Kudoh S.

Kekkaku. 2013 Aug;88(8):625-8. Japanese.

PMID:
24044166
33.

Stress related to care: the impact of childhood cancer on the lives of parents.

dos Santos Alves DF, de Brito Guirardello E, Kurashima AY.

Rev Lat Am Enfermagem. 2013 Feb;21(1):356-62. English, Portuguese, Spanish.

34.

Multidrug-resistant tuberculosis with a history of nontuberculous Mycobacteriosis: a brief report of two cases.

Morimoto K, Yoshiyama T, Okumura M, Hoshino Y, Yoshimori K, Ogata H, Kurashima A, Gemma A, Kudoh S.

Intern Med. 2012;51(24):3435-7. Epub 2012 Dec 15.

35.

Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.

Saito T, Fujiuchi S, Tao Y, Sasaki Y, Ogawa K, Suzuki K, Tada A, Kuba M, Kato T, Kawabata M, Kurashima A, Sakatani M; NHO Pulmonary Fungosis Research Group.

Infection. 2012 Dec;40(6):661-7. doi: 10.1007/s15010-012-0322-x. Epub 2012 Sep 7.

PMID:
22956473
36.

Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases.

Harada T, Akiyama Y, Kurashima A, Nagai H, Tsuyuguchi K, Fujii T, Yano S, Shigeto E, Kuraoka T, Kajiki A, Kobashi Y, Kokubu F, Sato A, Yoshida S, Iwamoto T, Saito H.

J Clin Microbiol. 2012 Nov;50(11):3556-61. doi: 10.1128/JCM.01175-12. Epub 2012 Aug 22. Erratum in: J Clin Microbiol. 2013 Feb;51(2):736. J Clin Microbiol. 2013 Mar;51(3)1061.

37.

[Forefront of the clinic and research of pulmonary MAC disease].

Kurashima A, Ogawa K.

Kekkaku. 2012 May;87(5):433-48. Japanese. No abstract available.

PMID:
22848925
38.
39.

Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study.

Yoshida K, Kurashima A, Kamei K, Oritsu M, Ando T, Yamamoto T, Niki Y.

J Infect Chemother. 2012 Jun;18(3):378-85. doi: 10.1007/s10156-012-0414-7. Epub 2012 Apr 24.

PMID:
22526387
40.

Association of SLC11A1 (NRAMP1) polymorphisms with pulmonary Mycobacterium avium complex infection.

Sapkota BR, Hijikata M, Matsushita I, Tanaka G, Ieki R, Kobayashi N, Toyota E, Nagai H, Kurashima A, Tokunaga K, Keicho N.

Hum Immunol. 2012 May;73(5):529-36. doi: 10.1016/j.humimm.2012.02.008. Epub 2012 Feb 16.

PMID:
22387151
41.

[Treatment of relatively rare species nontuberculous pulmonary mycobacteriosis].

Kurashima A.

Kekkaku. 2011 Dec;86(12):923-32. Japanese.

PMID:
22338346
42.

[Factors related to the occurrence of multi- (extensively-) drug resistant tuberculosis (M/XDR-TB) in our hospital].

Okumura M, Yoshiyama T, Ogata H, Morimoto K, Kokuto H, Kurashima A, Kudoh S.

Kekkaku. 2011 Nov;86(11):863-8. Japanese.

PMID:
22250465
43.

Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan.

Mori S, Tokuda H, Sakai F, Johkoh T, Mimori A, Nishimoto N, Tasaka S, Hatta K, Matsushima H, Kaise S, Kaneko A, Makino S, Minota S, Yamada T, Akagawa S, Kurashima A; NTM-BIORA (NTM infection in Biologic-treated RA patients) Study Investigators.

Mod Rheumatol. 2012 Sep;22(5):727-37. doi: 10.1007/s10165-011-0577-6. Epub 2011 Dec 30.

44.

[A case of drug-induced pneumonitis caused by saikokeishikankyoto].

Imai Y, Morimoto K, Yoshimori K, Kurashima A, Ogata H, Kudoh S.

Nihon Kokyuki Gakkai Zasshi. 2011 Sep;49(9):688-91. Japanese.

PMID:
22073616
45.

[Brain tumor (germinoma) diagnosed after assessment for male late-onset hypogonadism syndrome: a case report].

Amano T, Seki M, Imao T, Takemae K, Kurashima A.

Hinyokika Kiyo. 2011 Aug;57(8):459-62. Japanese.

46.

[Nontuberculous mycobacteriosis mortality in Japan].

Morimoto K, Iwai K, Ohmori M, Okumura M, Yoshiyama T, Yoshimori K, Ogata H, Kurashima A, Kudoh S.

Kekkaku. 2011 May;86(5):547-52. Japanese.

PMID:
21735860
47.

Mycobacterium heckeshornense lung infection that was diagnosed as Mycobacterium xenopi disease by DNA-DNA hybridization (DDH).

Morimoto K, Kazumi Y, Maeda S, Yoshimori K, Yoshiyama T, Ogata H, Kurashima A, Kudoh S.

Intern Med. 2011;50(11):1251-3. Epub 2011 Jun 1.

48.

Reversion rates of QuantiFERON-TB Gold are related to pre-treatment IFN-gamma levels.

Komiya K, Ariga H, Nagai H, Kurashima A, Shoji S, Ishii H, Nakajima Y.

J Infect. 2011 Jul;63(1):48-53. doi: 10.1016/j.jinf.2011.05.006. Epub 2011 May 17.

PMID:
21624664
49.

Clinical efficacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis: a prospective observational study.

Kohno S, Izumikawa K, Kakeya H, Miyazaki Y, Ogawa K, Amitani R, Niki Y, Kurashima A.

Med Mycol. 2011 Oct;49(7):688-93. doi: 10.3109/13693786.2011.561369. Epub 2011 Feb 28.

PMID:
21355713
50.

Stratified Threshold Values of QuantiFERON Assay for Diagnosing Tuberculosis Infection in Immunocompromised Populations.

Ariga H, Nagai H, Kurashima A, Hoshino Y, Shoji S, Nakajima Y.

Tuberc Res Treat. 2011;2011:940642. doi: 10.1155/2011/940642. Epub 2011 Jun 27.

Supplemental Content

Loading ...
Support Center